小摩：予中国人寿(02628)“增持”评级 目标价15港元
摩根大通发布报告称，予中国人寿(02628)“增持”评级，预计2024/25年CSM余额分别为7760亿及7880亿元人民币，预期2024年底至2026年底公司核心偿付能力充足率分别约134%、127%及121%，目标价15港元。
该行预计，中国人寿2024财年纯利同比升4%至为480亿元人民币，然而，在未来三年(2024-2026年)，预计年度盈利增长率为6%，因为预期合约服务边际(CSM)余额将于2026财年末反弹至8080亿元人民币，料2024财年股息为0.51元人民币，股息率为6%。
Reprinted from 引领外汇网，the copyright all reserved by the original author.
Disclaimer: The content above represents only the views of the author or guest. It does not represent any views or positions of FOLLOWME and does not mean that FOLLOWME agrees with its statement or description, nor does it constitute any investment advice. For all actions taken by visitors based on information provided by the FOLLOWME community, the community does not assume any form of liability unless otherwise expressly promised in writing.
FOLLOWME Trading Community Website: https://www.followme.com
Hot
No comment on record. Start new comment.